2025. Clinical Predictors of Response to Treatment with Tofacitinib (Janus Kinase Inhibitor) in Patients with Ankylosing Spondylitis. Indus Journal of Bioscience Research. 3, 4 (Apr. 2025), 175–181. DOI:https://doi.org/10.70749/ijbr.v3i4.1020.